NDRA ENDRA Life Sciences Inc.
Healthcare$5.31+0.00%OpenMarket Cap: $4.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.67
P/S
0.00
EV/EBITDA
-0.67
DCF Value
$-0.12
FCF Yield
-194.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-513.2%
ROA
-212.4%
ROIC
-236.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.2M | $-1.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.6M | $-3.2M | $— | — |
| FY null | $0.00 | NaN% | $-5.8M | $-7.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.4M | $-1.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.3M | $-1.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.5M | $-1.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.3M | $-4.1M | $— | — |
| FY null | $0.00 | NaN% | $-10.8M | $-11.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.5M | $-2.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.2M | $-2.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.8M | $-2.8M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-1.5M | $-1.5M | $-0.85 | — |